Dr Morse is a Associate Visiting Surgeon in the Dept of Surgery and an Assistant Professor of Surgery at Harvard Medical School. He serves as the Co-Director of the Gastroesophageal Surgery Program.
- Centers & Specialties
- Clinical Interests
- Esophageal cancer
- Minimally invasive esophageal resections (esophagectomy)
- Laparoscopic antireflux surgery/GERD
- Laparoscopic paraesophageal hernia repair
- Laparoscopic re-operative antireflux surgery
- Barrett's esophagus
- Esophageal cancer, Barrett's esophagus
- Esophageal disease
- Esophageal anomalies
- Lung cancer
- Minimally invasive pulmonary (lung) resections
- Airway surgery
- Thoracic surgery
- Benign and malignant diseases of the chest
- Idiopathic Laryngotracheal Stenosis
- Medical Education
- MD, Columbia University College of Physicians and Surgeons
- Residency, Massachusetts General Hospital
- Board Certifications
- Thoracic Surgery
- Boston: Massachusetts General Hospital
- Lowell: Lowell General Hospital
- Salem: North Shore Medical Center
- Insurances Accepted
- Aetna Health Inc.
- Beech Street
- Blue Cross Blue Shield - Blue Care 65
- Blue Cross Blue Shield - Indemnity
- Blue Cross Blue Shield - Managed Care
- Blue Cross Blue Shield - Partners Plus
- Cigna (PAL #'s)
- Fallon Community HealthCare
- Great-West Healthcare (formally One Health Plan)
- Harvard Pilgrim Health Plan - ACD
- Harvard Pilgrim Health Plan - PBO
- Health Care Value Management (HCVM)
- Humana/Choice Care PPO
- Medicare - ACD
- Neighborhood Health Plan - ACD
- Neighborhood Health Plan - PBO
- OSW - Connecticut
- OSW - Maine
- OSW - New Hampshire
- OSW - Rhode Island
- OSW - Vermont
- Private Health Care Systems (PHCS)
- Railroad Medicare
- Railroad Medicare - ACD
- Senior Whole Health
- Tufts Health Plan
- United Healthcare (non-HMO) - ACD
- United Healthcare (non-HMO) - PBO
- Patient Age Group
Dr Morse graduated from Columbia University College of Physicians and Surgeons. He did both his surgical residencies at the MGH, first in general surgery and then in Cardiothoracic Surgery. Dr. Morse went on complete a second fellowship in minimally invasive thoracic surgery with a particular emphasis on esophageal surgery. He is Board certified in both Surgery and Thoracic Surgery.
Dr Morse is clinically very active and sees new patients weekly. His clinical interests revolve around malignancies of the chest, especially lung and esophageal cancer, as well as the treatment a variety of benign esophageal conditions, including achalasia, paraesophageal hernia and gastroesophageal reflux disease. Dr. Morse has taken a lead role in the development of a minimally invasive esophagectomy program at MGH. This work has led to a number of manuscripts including a direct comparison of open vs. minimally invasive esophagectomy.
Dr. Morse serves as the co-director of the MGH Gastroesophageal Surgery program and participates on workforces in several national thoracic societies.
- Research Summary
My research is primarily related to outcomes of the diseases I treat. I am especially focused on esophageal cancer and participate in an international esophagectomy complications consensus group. I have published extensively on minimally invasive esophageal resections. I was also recently the editor of a textbook, Master Techniques in Surgery: Thoracic Surgery, describing detailed techniques of thoracic surgery with an international group of authors.
- Tapias-Vargas LF, Morse CR. Minimally Invasive Ivor Lewis Esophagectomy after Induction Therapy Yields Similar Early Outcomes to Surgery Alone. Innovations. 2011 Sep;6(5):331-6
- Tapias-Vargas LF, Morse CR. A Preliminary Experience with Minimally Invasive Ivor Lewis Esophagectomy. Dis Esophagus. 2012 Jul;25(5):449-55.
- Sihag S, Wright CD, Wain JC, Lanuti M, Gaissert HA, Donahue DA, Mathisen DJ, Morse CR. Comparison of Perioperative Outcomes Following Open vs Minimally Invasive Ivor Lewis Esophagectomy at Single High-Volume Center. Eur J Cardiothorac Surg 2012 Sep;42(3):430-7.
- Tapias-Vargas LF, Morse CR. Minimally invasive Ivor Lewis Esophagectomy: Description of a learning curve. Journal of the American College of Surgeons. 2014 Jun; 218(6):1130-40.
Bob Hazelton lived with chronic acid reflux for years and was diagnosed with esophageal cancer in 2011. After his surgical team at Massachusetts General Hospital performed a minimally invasive esophagectomy, Bob has a healthy esophagus and is getting back to his active lifestyle.
Christopher Morse, MD, of the Division of Thoracic Surgery at Massachusetts General Hospital has been able to remove esophageal tumors using an innovative minimally invasive procedure that offers patients less postoperative pain and a shorter recovery time
Minimally Invasive Esophagectomy (MIE)
Minimally invasive esophagectomy (MIE) is a procedure performed by Massachusetts General Hospital surgeons using small incisions to remove a diseased esophagus and reconstruct the gastrointestinal tract. For more information, visit massgeneral.org/MIE
Preview clip of Digestive Healthcare Center CME program
Christopher Morse, MD, reviews minimally invasive treatments for esophageal cancer, including esophageal resections. Please note that this video contains images from a real procedure and may cause discomfort for some viewers.
55 Fruit Street
Boston MA, 02114-2696